Israel Active

Israel’s WizeCare offers physiotherapists and clinicians an app that enables them to guide their patients during their at-home rehabilitation exercises. It has partnered with the Cleveland Clinic for their staff to provide personalized videos for patients and monitor compliance.

Up to 40% of cancer patients develop secondary brain tumors shortly after surgery to remove a primary tumor elsewhere in the body. Researchers at Tel Aviv University have shown that an intravenous injection of CpG-C (synthetic DNA material) can prevent these metastases forming.

Malaria kills half-a-million people annually. In this “Weizmann in Focus” video, Dave Doneson explains that current anti-malaria vaccines break down in hot climates. However, scientists at Israel’s Weizmann Institute redesigned the protein RH5 to enable the vaccine to be stored at room temperature.

In lab tests on aging and the immune system, biologists at Israel’s Ben Gurion University have profiled over 24,000 T-Cells. They identified that 30% deteriorate during the aging process and could establish new areas of medical intervention to prevent age-related illnesses.

I reported previously on Israeli startup Telesofia when it developed personalized medical videos. Now Israel’s Sheba Medical Center is to pilot Telesofia’s tele-medicine software for cancer patients at home to communicate with doctors about chemotherapy side effects.

Israeli researchers at Sheba Medical Center have found that a medication used to treat Alzheimer’s patients also has strong therapeutic effects on autistic children. 60 such children were given Donepezil and Cholin for six months and their language skills improved significantly.

Israel’s Biobeat develops wireless products (wristwatch and patch) to measure blood pressure, oxygenation, pulse, stroke volume and more. Both items sync data to the cloud, enabling remote monitoring. The US FDA has just given clearance to the combined products.

Thanks to Israeli discoveries and research, patients with the bone marrow cancer multiple myeloma are leading longer, better lives.

Scientists at Tel Aviv University have developed a novel nano-vaccine for melanoma (skin cancer) that has proved effective in laboratory tests. Tiny particles made of bio-degradable polymer were packed with two “safe” cancer-expressed peptides for the body to develop immunity against.

Kalai Housam Tarif, an Israeli Prison Officer of the Druze community, donated half of his liver to an unrelated eight-year-old boy from Jordan. Surgeons at Schneider Children’s Medical Center in Petach Tikvah transplanted around half of Tarif’s liver to save the boy.